Clinical Trial Update: A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating safety, cellular kinetics, and exploratory efficacy of Rapcabtagene Autoleucel in rheumatoid arthritis and Sjögren's…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Sjögren Syndrome

Drugs mentioned

• Rapcabtagene Autoleucel

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD) | Phase 1, Phase 2 | Status: RECRUITING